Submit Deal

CHARLES RIVER LABORATORIES INTERNATIONAL INC

Summary

Charles River Laboratories was founded in 1947 and is a provider of drug discovery and development services.

Deals Overview

Total Deals15

Valued Deals12

Total Value£ 3.00 B

Avg. Deal Size£ 250 M

Market Context

Senior Management

James Foster
President and CEO
Flavia Pease
CFO
David R. Smith
CFO

Sort

wil research laboratories inc.

HQ - United States

Health Care Facilities

4 Apr 2016

Investment Date

100%

Stake

£ 450 M

Deal Value

mpi research inc

HQ - United States

Medical Equipment

3 Apr 2018

Investment Date

100%

Stake

£ 578 M

Deal Value

hemacare corporation

HQ - United States

Medical Supplies

Health Care Services

3 Jan 2020

Investment Date

100%

Stake

£ 252 M

Deal Value

cognate bioservices

HQ - United States

Biotechnology

29 Mar 2021

Investment Date

100%

Stake

£ 628 M

Deal Value

charles river laboratories (rms japan)

HQ - Japan

Facilities Technology

12 Oct 2021

Investment Date

100%

Stake

£ 46 M

Deal Value

bit.bio

HQ - United Kingdom

Biotechnology

5 Nov 2021

Investment Date

£ 76 M

Deal Value

explora biolabs

HQ - United States

Biotechnology

6 Apr 2022

Investment Date

100%

Stake

£ 224 M

Deal Value

charles river (avian vaccine services business)

HQ - United States

Biotechnology

5 Jan 2023

Investment Date

100%

Stake

n/a

Deal Value

samdi tech

HQ - United States

Pharmaceuticals

30 Jan 2023

Investment Date

80%

Stake

£ 40 M

Deal Value

charles river laboratories international (south san francisco facility)

HQ - United States

Pharmaceuticals

4 Mar 2025

Investment Date

100%

Stake

n/a

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy